Company news
Mindbio Therapeutics Corp. (CSE:MBIO) news
Mindbio Therapeutics Corp. news releases on 6ix. Latest, May 11, 2026: MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Press releases & updates
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
May 11, 2026
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
May 5, 2026
MindBio Files Patent Applications in 15 World Firsts
April 29, 2026
MindBio Appoints Market Maker Venture Liquidity Providers
April 13, 2026
MindBio Announces Closing of Private Placement
April 1, 2026
MindBio Announces Upsize to Private Placement up to $1.5 Million
March 19, 2026
MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation
February 24, 2026
MindBio Announces Private Placement to Raise up to $650,000
February 18, 2026
MindBio to Revolutionise Drug and Alcohol Testing in the Mining Industry using AI Voice-Based Drug & Alcohol Detection Solution
February 2, 2026
MindBio Lists for Trading on OTCQB Market
January 21, 2026
MindBio Raises $1.1 Million in Private Placement
December 12, 2025
MindBio Announces Private Placement
November 26, 2025
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
July 8, 2025
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
July 7, 2025
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
March 5, 2025
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
February 27, 2025
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 11, 2025